Tangible Shareholders Equity: The value shareholders equity less intangible assets.
Pulse Biosciences, Inc (PLSE) had Tangible Shareholders Equity of $77.29M for the most recently reported fiscal year, ending 2025-12-31.
| Income Statement Financials | |
$0.35M |
|
$-72.78M |
|
$0.54M |
|
$-0.19M |
|
$77.29M |
|
$-76.94M |
|
$4.16M |
|
$-72.78M |
|
$-72.78M |
|
$-72.78M |
|
$-72.78M |
|
$-72.78M |
|
$-72.78M |
|
$-76.94M |
|
$-75.87M |
|
67.39M |
|
67.39M |
|
$-1.08 |
|
$-1.08 |
|
| Balance Sheet Financials | |
$83.42M |
|
$1.05M |
|
$11.12M |
|
$94.54M |
|
$7.92M |
|
-- |
|
$5.96M |
|
$13.88M |
|
$80.66M |
|
|
Tangible Shareholders Equity |
$77.29M |
$80.66M |
|
67.84M |
|
| Cash Flow Statement Financials | |
$-54.12M |
|
$-0.34M |
|
$17.15M |
|
$118.04M |
|
$80.73M |
|
$-37.30M |
|
$21.46M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
10.53 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-54.00% |
|
-21982.57% |
|
-21982.57% |
|
-21676.57% |
|
-20794.57% |
|
-20794.57% |
|
$-54.44M |
|
-- |
|
-- |
|
-- |
|
0.00 |
|
3.96 |
|
1.28 |
|
285.74 |
|
-90.24% |
|
-94.17% |
|
-76.99% |
|
-90.24% |
|
$1.19 |
|
$-0.81 |
|
$-0.80 |
|